Work

Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOLIZUMAB FOR IMMUNE CHECKPOINT INHIBITOR RELATED COLITIS

Year: 2023

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(23)03549-7

Authors: Yinghong Wang, Krishnavathana Varatharajalu, Malek Shatila, Anusha Shirwaikar Thomas, Kristin Junek, Ninoska Silva, Pavlos Msaouel, Bilal Siddiqui, Jianbo Wang, John Araujo, Matthew T. Campbell, Rodabe Amaria, Natalie Vokes

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4383420787

Cites:

Cited by: 2

Related to: 10